Evidence map›Paper›PMID 32454915›Full record

ArticleCanadian respiratory journal2020

Identification of a Mutation in the Novel Compound Heterozygous CFTR in a Chinese Family with Cystic Fibrosis.

Hongxia Shao, Jingna Hua, Qi Wu, Xiaoge Li, Ming Zhang, Herong Wang, Junping Wu, Long Xu, Yi Xie, Li Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Canadian respiratory journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Hongxia ShaoDepartment of Respiratory Medicine, Haihe Hospital, Tianjin University, Tianjin 300350, China.
Jingna HuaDepartment of Respiratory Medicine, Haihe Hospital, Tianjin University, Tianjin 300350, China.
Qi WuDepartment of Respiratory Medicine, Haihe Hospital, Tianjin University, Tianjin 300350, China.ORCID 0000-0002-8172-649X
Xiaoge LiTianjin Jinnan Xiaozhan Hospital, Tianjin 300353, China.
Ming ZhangDepartment of Medical Ultrasonics, Haihe Hospital, Tianjin University, Tianjin 300350, China.
Herong WangDepartment of Respiratory Medicine, Haihe Hospital, Tianjin University, Tianjin 300350, China.
Junping WuTianjin Institute of Respiratory Diseases, Tianjin 300350, China.
Long XuDepartment of Science and Education, Haihe Hospital, Tianjin University, Tianjin 300350, China.
Yi XieDepartment of Science and Education, Haihe Hospital, Tianjin University, Tianjin 300350, China.
Li LiDepartment of Respiratory Medicine, Haihe Hospital, Tianjin University, Tianjin 300350, China.ORCID 0000-0002-0140-1995
Huaiyong ChenTianjin Institute of Respiratory Diseases, Tianjin 300350, China.ORCID 0000-0002-1201-0535
Tianjin University · CNTianjin Hospital · CNTianjin Infectious Diseases Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) is one of the most common autosomal recessive disorders among Caucasians of Northern European descent but is uncommon in the Chinese population.

Indexed as

Cystic FibrosisFamilyRespiratory Tract InfectionsAdultChinaCystic Fibrosis Transmembrane Conductance RegulatorExome SequencingFemaleHeterozygoteHigh-Throughput Nucleotide SequencingHumansLungMaleMutationPedigreePseudomonas aeruginosaCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID32454915
PMCPMC7229557
OpenAlexW3022912740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.